BKT140

Search structure
Status: Phase 2
Entry Type: Protein
Molecule Category: UNKNOWN
UNII: DA9G065962

Indications

Mesh Heading Maximum Phase Reference
Adenocarcinoma Phase 1/Phase 2 ClinicalTrials
Anemia; Anemia, Aplastic; Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1/Phase 2 ClinicalTrials
Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid Phase 1/Phase 2 ClinicalTrials
Adenocarcinoma Phase 1/Phase 2 ClinicalTrials
Adenocarcinoma Phase 2 ClinicalTrials
Hodgkin Disease; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase 2 ClinicalTrials
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute Phase 1/Phase 2 ClinicalTrials
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute Phase 2 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3545348
FDA SRS DA9G065962
CONTENTS